Application of High-resolution Magnetic Resonance Imaging in Measuring Olfactory Bulb Volume in Patients with Alzheimer Disease
-
摘要:
目的 评价阿尔茨海默病(Alzheimer disease, AD)患者嗅球体积变化。 方法 对14例AD患者及25名正常老年志愿者行高分辨嗅球磁共振成像(magnetic resonance imaging, MRI), 测量嗅球体积。 结果 AD患者较大侧嗅球体积为(32.2±7.7)mm3, 小于正常老年志愿者的(40.6±6.6)mm3(P=0.002)。AD患者嗅球体积与简易精神状态检查量表(mini-mental state examination, MMSE)评分无明显相关性(P=0.205)。 结论 AD患者嗅球体积减小, 符合神经病理学表现。MRI可以发现AD患者嗅球体积改变, 可能为AD诊断提供帮助。 Abstract:Objective To explore the change of olfactory bulb (OB) volume in patients with Alzheimer disease (AD) and assess the value of high-resolution magnetic resonance imaging (MRI) in measuring OB volume. Methods Fourteen AD patients and 25 normal aging volunteers (control group) underwent high-resolution MRI imaging of OB and the OB volume was measured. Results The OB volume in AD patients[(32.2±7.7) mm3] was significantly smaller than that in control group[(40.6±6.6) mm3](P=0.002). The OB volume in AD patients didn't correlate significantly with their mini-mental state examination (MMSE) scores (P=0.205). Conclusions AD patients show more prominent OB atrophy than normal aging volunteers do, which is in agreement with the pathological findings. High-resolution MRI is valuable in identifying the change of OB volume and therefore might be beneficial for AD diagnosis. -
Key words:
- Alzheimer disease /
- magnetic resonance imaging /
- olfactory bulb
-
表 1 AD患者及正常老年志愿者嗅球体积(mm3)
组别 右侧嗅球体积 左侧嗅球体积 较大侧嗅球体积 正常志愿者 39. 7 ± 6. 5 37. 2 ± 7. 9 40. 6 ± 6. 6 AD患者 2. 1 ± 7. 8* 26. 1 ± 10. 3** 32. 2 ± 7. 7*** AD患者与正常志愿者比较,独立样本t检验,* t = - 3. 022,P = 0. 005; **t = - 3. 523,P = 0. 001; ***t = - 3. 344,P = 0. 002 -
[1] Hof PR, Glannakopoulos P, Bouras C. The neuropathological changes associated with normal brain aging[J]. Histol Histopathol, 1996, 11:1075-1088. http://www.ncbi.nlm.nih.gov/pubmed/8930649 [2] Wesson DW, Levy E, Nixon RA, et al. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model[J]. J Neurosci, 2010, 13:505-514. http://europepmc.org/articles/PMC2826174/ [3] Christen-Zaech S, Kraftsik R, Pillevuit O, et al. Early olfactory involvement in Alzheimer's disease[J]. Can J Neurol Sci, 2003, 30:20-25. doi: 10.1017/S0317167100002389 [4] Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment[J]. Clin Neuropathol, 2006, 25:265-271. http://www.ncbi.nlm.nih.gov/pubmed/17140156 [5] Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease:an autopsy study[J]. J Alzheimers Dis, 2005, 7:149-157; discussion 173-180. doi: 10.3233/JAD-2005-7208 [6] ter Laak HJ, Renkawek K, van Workum FP. The olfactory bulb in Alzheimer disease:a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction[J]. Alzheimer Dis Assoc Disord, 1994, 8:38-48. doi: 10.1097/00002093-199424003-00005 [7] McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease[J]. Neurology, 1984, 34:939-944. doi: 10.1212/WNL.34.7.939 [8] Handley OJ, Morrison CM, Miles C, et al. ApoE gene and familial risk of Alzheimer's disease as predictors of odour identification in older adults[J]. Neurobiol Aging, 2006, 27:1425-1430. doi: 10.1016/j.neurobiolaging.2005.08.001 [9] Calhoun-Haney R, Murphy C. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores[J]. Brain Cogn, 2005, 58:178-182. doi: 10.1016/j.bandc.2004.10.004 [10] Velayudhan L, Lovestone S. Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil[J]. J Clin Psychopharmacol, 2009, 29:387-390. doi: 10.1097/JCP.0b013e3181aba5a5 [11] Wilson RS, Arnold SE, Schneider JA, et al. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age[J]. J Neurol Neurosurg Psychiatry, 2007, 78:30-35. doi: 10.1136/jnnp.2006.099721 [12] Thomann PA, Dos Santos V, Seidl U, et al. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease[J]. J Alzheimers Dis, 2009, 17:213-221. doi: 10.3233/JAD-2009-1036 [13] Gomez-Isla T, Price JL, McKeel DW Jr, et al. Profound loss of layer Ⅱ entorhinal cortex neurons occurs in very mild Alzheimer's disease[J]. J Neurosci, 1996, 16:4491-4500. doi: 10.1523/JNEUROSCI.16-14-04491.1996 [14] Rodrigue KM, Raz N. Shrinkage of the entorhinal cortex over five years predicts memory performance in healthy adults[J]. J Neurosci, 2004, 24:956-963. doi: 10.1523/JNEUROSCI.4166-03.2004
计量
- 文章访问数: 203
- HTML全文浏览量: 51
- PDF下载量: 4
- 被引次数: 0